Skip to main content
Log in

EMA says companies should test for nitrosamine impurities

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. CHMP = Committee for Medicinal Products for Human Use

  2. NDEA = N-nitrosodiethylamine; NDMA = N-nitrosodimethylamine; NMBA = N-Nitroso-N-methyl-4-aminobutyric acid. Also see Reactions 1744 p5; 803379732

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

EMA says companies should test for nitrosamine impurities. Reactions Weekly 1774, 2 (2019). https://doi.org/10.1007/s40278-019-68449-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-68449-6

Navigation